SHPH Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for Shuttle Pharmaceuticals Holdings Inc (SHPH.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Shuttle Pharmaceuticals Holdings Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

SHPH News & Events

Events Timeline

No data

News

5.0

2025-11-29NASDAQ.COM

Shuttle Pharma Names Christopher Cooper as Acting CFO

9.5

2025-11-24Benzinga

LexinFintech Shares Surge Over 15%; Check Out 20 Stocks Making Moves in Premarket Trading

2.0

2025-11-21Benzinga

What Caused the Overnight Surge in Shuttle Pharmaceuticals (SHPH) Stock?

People Also Watch

Frequently Asked Questions

What is Shuttle Pharmaceuticals Holdings Inc (SHPH) stock price today?

The current price of SHPH is 1.99 USD — it has increased 10.56 % in the last trading day.

What is Shuttle Pharmaceuticals Holdings Inc (SHPH)'s business?

Shuttle Pharmaceuticals Holdings, Inc. is a discovery and development stage specialty pharmaceutical company focused on improving the outcomes for cancer patients treated with radiation therapy (RT). Its product candidates include Ropidoxuridine, a Phase II, clinical-stage radiation sensitizer, a platform of HDAC inhibitors (SP-1-161, SP-2-225 and SP-1-303), and two preclinical, prostate cancer-oriented diagnostics assets: PC-RAD Test, a blood test to predict clinical response to radiation therapy and PSMA-B ligand for potential use as a theranostic agent. Ropidoxuridine (IPdR) is for use in combination with RT to treat brain tumors (glioblastoma) and sarcomas. SP-1-161 is a candidate lead of compounds demonstrating activation of the ATM gene product (mutated in Ataxia-Telangiectasia). SP-2-225 is a candidate lead of compounds demonstrating Class II (HDAC6) selective inhibition. SP-1-303 is a candidate Class I HDAC inhibitor with preferential efficacy against ER positive cancers.

What is the price predicton of SHPH Stock?

Wall Street analysts forecast SHPH stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SHPH is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Shuttle Pharmaceuticals Holdings Inc (SHPH)'s revenue for the last quarter?

Shuttle Pharmaceuticals Holdings Inc revenue for the last quarter amounts to 0.00 USD, decreased % YoY.

What is Shuttle Pharmaceuticals Holdings Inc (SHPH)'s earnings per share (EPS) for the last quarter?

Shuttle Pharmaceuticals Holdings Inc. EPS for the last quarter amounts to -1.05 USD, decreased -97.35 % YoY.

What changes have occurred in the market's expectations for Shuttle Pharmaceuticals Holdings Inc (SHPH)'s fundamentals?

The market is revising No Change the revenue expectations for SHPH for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -58.19%.

How many employees does Shuttle Pharmaceuticals Holdings Inc (SHPH). have?

Shuttle Pharmaceuticals Holdings Inc (SHPH) has 9 emplpoyees as of January 09 2026.

What is Shuttle Pharmaceuticals Holdings Inc (SHPH) market cap?

Today SHPH has the market capitalization of 3.46M USD.